col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


16 Ergebisse       Seite 1

 [1] 
Elsevier: Leukemia Research
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Nov―08 COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: the UK experience. Giovanna Lucchini, Elena Cozma, Aimee Jackson, Kimberly Gilmour, Rachel Protheroe, Keith Wilson, et al. (+18)
2 [GO] 2023―Jun―22 mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect Nil Albiol, Elionor Lynton-Pons, Olga Aso, Esther Moga, Silvia Vidal, Lucía Gómez-Pérez, et al. (+10)
3 [GO] 2023―Mai―29 Humoral and Cellular Responses after Third Dose of SARS-CoV-2 Vaccine in Myeloproliferative Neoplasms Patients on Ruxolitinib Therapy A. Atanasio, A. Vanni, L. Maggi, S. Pilerci, A. Mazzoni, M. Capone, et al. (+11)
4 [GO] 2023―Mai―17 Specific Immune Response to mRNA Vaccines Against COVID-19 in Patients Receiving Allogeneic Stem Cell Transplantation for Myeloid Malignancy Was Altered by Immunosuppressive Therapy Jana Macková, Petr Hainz, Jitka Kryštofová, Kateřina Roubalová, Markéta Šťastná-Marková, Šárka Vaníková, et al. (+3)
5 [GO] 2022―Okt―20 TREATING LYMPHOMA IN THE PANDEMIC ERA: WHAT WE LEARNED FROM OUR EXPERIENCE AT FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI G. Gattuso, V. Biassoni, M. Podda, C. Meazza, S. Chiaravalli, O. Nigro, et al. (+8)
6 [GO] 2022―Jun―25 2022 update on the clinical outcome of coronavirus disease 2019 in haemato-oncology patients Susie Bradwell, Luke Hone, Kirstie Thorneycroft, Jonathan Lambourne, James A. Aries, Jeffrey K. Davies, et al. (+2)
7 [GO] 2022―Jun―20 Characteristics and clinical outcomes of SARS-CoV-2 infection in adult patients with acute leukemia in France Pierre-Yves Dumas, Sarah Bertoli, Caroline Bonmati, Martin Carre, Juliette Lambert, Mario Ojeda-Uribe, et al. (+18)
8 [GO] 2022―Mrz―04 Longer-term response to SARS-CoV-2 vaccine in MPN patients: role of ruxolitinib and disease severity. Giuseppe Auteri, Daniela Bartoletti, Christian Di Pietro, Emanuele Sutto, Camilla Mazzoni, Andrea Davide Romagnoli, et al. (+4)
9 [GO] 2021―Apr―24 High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies Alex Niu, Bo Ning, Francisco Socola, Hana Safah, Tim Reynolds, Moayed Ibrahim, et al. (+6)
10 [GO] 2021―Apr―24 Personalized at-home autologous hematopoietic stem cell transplantation during the SARS-CoV-2 outbreak Alexandra Martínez-Roca, Luis Gerardo Rodríguez-Lobato, Nuria Ballestar Dot, Cristina Gallego Miralles, Francesc Fernández-Avilés
11 [GO] 2021―Jan―27 The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid Fernando Martín-Moro, Claudia Núnez-Torrón, Lucía Pérez-Lamas, Carlos Jiménez-Chillón, Juan Marquet-Palomanes, Javier López-Jiménez, Pilar Herrera-Puente
12 [GO] 2021―Jan―20 Reinfection Versus Failure of Viral Clearance in a COVID-19 Patient with Hematologic Malignancy Moayed Ibrahim, Andrew Vegel, Alex Niu, Ketaki Panse, Rebecca Chen, Hana Safah, et al. (+3)
13 [GO] 2020―Nov―13 Lymphocyte-Depleting Chemotherapy for Aggressive Hematologic Malignancies in Two Patients with Positive SARS-CoV-2 PCR Ari Pelcovits, Aakriti Pandita, Dimitrios Farmakiotis, Pamela Egan
14 [GO] 2020―Jun―30 Immunosuppression in hematological cancer patients with Covid-19 - uncomplicated infections but delayed viral clearance? Karen Boyd, Benjamin Parcell, Sudhir Tauro
15 [GO] 2020―Apr―30 Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia S. Paneesha, G. Pratt, H. Parry, P. Moss
16 [GO] 2020―Mrz―26 Acute Leukemia in the Time of COVID-19 Mathilde Gavillet, Jeanette Carr Klappert, Olivier Spertini, Sabine Blum
 [1] 

16 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec